I G Petrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 6:06 am

Competitors of I G Petrochemicals Ltd

All Competitor Stocks of I G Petrochemicals Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:55 am

Below is a detailed analysis of the quarterly data for I G Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 480.00 Cr.. The value appears to be declining and may need further review. It has decreased from 558.00 Cr. (Dec 2024) to 480.00 Cr., marking a decrease of 78.00 Cr..
• For Expenses, as of Mar 2025, the value is 431.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 512.00 Cr. (Dec 2024) to 431.00 Cr., marking a decrease of 81.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Dec 2024) to 49.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Mar 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Dec 2024) to 10.00%, marking an increase of 2.00%.
• For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Dec 2024) to 5.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Dec 2024) to 11.00 Cr., marking an increase of 8.00 Cr..
• For Depreciation, as of Mar 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 16.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Dec 2024) to 27.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Mar 2025, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 22.00%.
• For Net Profit, as of Mar 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Dec 2024) to 21.00 Cr., marking a decrease of 7.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 6.81. The value appears to be declining and may need further review. It has decreased from 9.01 (Dec 2024) to 6.81, marking a decrease of 2.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:24 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:21 pm

Below is a detailed analysis of the balance sheet data for I G Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,297.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,209.00 Cr. (Mar 2024) to 1,297.00 Cr., marking an increase of 88.00 Cr..
• For Borrowings, as of Mar 2025, the value is 238.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 337.00 Cr. (Mar 2024) to 238.00 Cr., marking a decrease of 99.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 602.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 517.00 Cr. (Mar 2024) to 602.00 Cr., marking an increase of 85.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,094.00 Cr. (Mar 2024) to 2,168.00 Cr., marking an increase of 74.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,016.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,030.00 Cr. (Mar 2024) to 1,016.00 Cr., marking a decrease of 14.00 Cr..
• For CWIP, as of Mar 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 41.00 Cr., marking an increase of 38.00 Cr..
• For Investments, as of Mar 2025, the value is 242.00 Cr.. The value appears to be declining and may need further review. It has decreased from 252.00 Cr. (Mar 2024) to 242.00 Cr., marking a decrease of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 868.00 Cr.. The value appears strong and on an upward trend. It has increased from 809.00 Cr. (Mar 2024) to 868.00 Cr., marking an increase of 59.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,168.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,094.00 Cr. (Mar 2024) to 2,168.00 Cr., marking an increase of 74.00 Cr..

Notably, the Reserves (1,297.00 Cr.) exceed the Borrowings (238.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for I G Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 12.83. This value is within the healthy range. It has decreased from 64.94 (Mar 23) to 12.83, marking a decrease of 52.11.
• For Diluted EPS (Rs.), as of Mar 24, the value is 12.83. This value is within the healthy range. It has decreased from 64.94 (Mar 23) to 12.83, marking a decrease of 52.11.
• For Cash EPS (Rs.), as of Mar 24, the value is 29.75. This value is within the healthy range. It has decreased from 80.34 (Mar 23) to 29.75, marking a decrease of 50.59.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 404.87. It has increased from 400.96 (Mar 23) to 404.87, marking an increase of 3.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 404.87. It has increased from 400.96 (Mar 23) to 404.87, marking an increase of 3.91.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 681.56. It has decreased from 763.79 (Mar 23) to 681.56, marking a decrease of 82.23.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 44.13. This value is within the healthy range. It has decreased from 110.28 (Mar 23) to 44.13, marking a decrease of 66.15.
• For PBIT / Share (Rs.), as of Mar 24, the value is 27.21. This value is within the healthy range. It has decreased from 94.88 (Mar 23) to 27.21, marking a decrease of 67.67.
• For PBT / Share (Rs.), as of Mar 24, the value is 17.34. This value is within the healthy range. It has decreased from 87.12 (Mar 23) to 17.34, marking a decrease of 69.78.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 12.83. This value is within the healthy range. It has decreased from 64.94 (Mar 23) to 12.83, marking a decrease of 52.11.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 12.83. This value is within the healthy range. It has decreased from 64.94 (Mar 23) to 12.83, marking a decrease of 52.11.
• For PBDIT Margin (%), as of Mar 24, the value is 6.47. This value is below the healthy minimum of 10. It has decreased from 14.43 (Mar 23) to 6.47, marking a decrease of 7.96.
• For PBIT Margin (%), as of Mar 24, the value is 3.99. This value is below the healthy minimum of 10. It has decreased from 12.42 (Mar 23) to 3.99, marking a decrease of 8.43.
• For PBT Margin (%), as of Mar 24, the value is 2.54. This value is below the healthy minimum of 10. It has decreased from 11.40 (Mar 23) to 2.54, marking a decrease of 8.86.
• For Net Profit Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 5. It has decreased from 8.50 (Mar 23) to 1.88, marking a decrease of 6.62.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 8. It has decreased from 8.50 (Mar 23) to 1.88, marking a decrease of 6.62.
• For Return on Networth / Equity (%), as of Mar 24, the value is 3.16. This value is below the healthy minimum of 15. It has decreased from 16.19 (Mar 23) to 3.16, marking a decrease of 13.03.
• For Return on Capital Employeed (%), as of Mar 24, the value is 5.31. This value is below the healthy minimum of 10. It has decreased from 19.50 (Mar 23) to 5.31, marking a decrease of 14.19.
• For Return On Assets (%), as of Mar 24, the value is 1.85. This value is below the healthy minimum of 5. It has decreased from 10.04 (Mar 23) to 1.85, marking a decrease of 8.19.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 0.2. It has increased from 0.13 (Mar 23) to 0.18, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.29. This value is within the healthy range. It has increased from 0.20 (Mar 23) to 0.29, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.02. It has decreased from 1.31 (Mar 23) to 1.02, marking a decrease of 0.29.
• For Current Ratio (X), as of Mar 24, the value is 1.51. This value is within the healthy range. It has decreased from 1.64 (Mar 23) to 1.51, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 24, the value is 1.15. This value is within the healthy range. It has decreased from 1.31 (Mar 23) to 1.15, marking a decrease of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 9.59. This value exceeds the healthy maximum of 8. It has decreased from 11.28 (Mar 23) to 9.59, marking a decrease of 1.69.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 77.93. This value exceeds the healthy maximum of 50. It has increased from 15.39 (Mar 23) to 77.93, marking an increase of 62.54.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 33.60. This value is within the healthy range. It has increased from 12.44 (Mar 23) to 33.60, marking an increase of 21.16.
• For Earning Retention Ratio (%), as of Mar 24, the value is 22.07. This value is below the healthy minimum of 40. It has decreased from 84.61 (Mar 23) to 22.07, marking a decrease of 62.54.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 66.40. This value is within the healthy range. It has decreased from 87.56 (Mar 23) to 66.40, marking a decrease of 21.16.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.47. This value is within the healthy range. It has decreased from 14.20 (Mar 23) to 4.47, marking a decrease of 9.73.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.30. This value is below the healthy minimum of 3. It has decreased from 9.36 (Mar 23) to 2.30, marking a decrease of 7.06.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,505.60. It has increased from 1,323.01 (Mar 23) to 1,505.60, marking an increase of 182.59.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 23) to 0.71, marking an increase of 0.15.
• For EV / EBITDA (X), as of Mar 24, the value is 11.08. This value is within the healthy range. It has increased from 3.90 (Mar 23) to 11.08, marking an increase of 7.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 23) to 0.63, marking an increase of 0.10.
• For Retention Ratios (%), as of Mar 24, the value is 22.06. This value is below the healthy minimum of 30. It has decreased from 84.60 (Mar 23) to 22.06, marking a decrease of 62.54.
• For Price / BV (X), as of Mar 24, the value is 1.06. This value is within the healthy range. It has increased from 1.03 (Mar 23) to 1.06, marking an increase of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 23) to 0.63, marking an increase of 0.10.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 23) to 0.02, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness